Clare Market Investments LLC Invests $343,000 in iShares Biotechnology ETF (NASDAQ:IBB)

Clare Market Investments LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 2,595 shares of the financial services provider’s stock, valued at approximately $343,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Cullen Frost Bankers Inc. raised its position in shares of iShares Biotechnology ETF by 1.5% during the fourth quarter. Cullen Frost Bankers Inc. now owns 5,654 shares of the financial services provider’s stock worth $748,000 after purchasing an additional 82 shares during the period. Transcend Capital Advisors LLC raised its holdings in iShares Biotechnology ETF by 0.8% during the 4th quarter. Transcend Capital Advisors LLC now owns 10,958 shares of the financial services provider’s stock worth $1,449,000 after buying an additional 92 shares during the period. Chicago Partners Investment Group LLC lifted its stake in iShares Biotechnology ETF by 2.5% in the fourth quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock valued at $510,000 after buying an additional 94 shares in the last quarter. WealthCare Investment Partners LLC boosted its holdings in shares of iShares Biotechnology ETF by 0.9% in the fourth quarter. WealthCare Investment Partners LLC now owns 10,348 shares of the financial services provider’s stock valued at $1,375,000 after buying an additional 96 shares during the period. Finally, Capital Investment Advisors LLC increased its position in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after acquiring an additional 99 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.8 %

Shares of NASDAQ:IBB opened at $135.84 on Tuesday. The firm has a market cap of $6.42 billion, a price-to-earnings ratio of 24.52 and a beta of 0.84. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The company’s fifty day simple moving average is $136.08 and its 200 day simple moving average is $140.22.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.